Abstract:A biological impact of the fused heterocyclic rings as anti-enzymatic agents was explored through experimental, theoretical and computational studies. The targeted hybrids of 1,2,4-triazole ( 8a–q ) were synthesized through multistep protocol. Initially, the carboxylate 3 was synthesized through stirring of 4-chlorobenzenesulfonyl chloride ( 1 ) and 4-(ethoxycarbonyl)piperidine ( 2 ) at room temperature. Carboxylate was converted into carbohydrazide 4 , which was refluxed with phenyl isothiocyanate and KOH to synthesize 1,2,4-triazole ( 6 ) through the formation of an intermediate hydrazinecarbothioamide (5) . A series of alkyl/aralkyl halides ( 7a–q ) were stirred at room temperature with compound 6 in the presence of Li(I) catalyst to avail the targeted library of hybrids ( 8a–q ). All the designed hybrids were screened for their acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), urease, hemolysis and biofilm inhibition potential and were found active with variable potential against all the evaluations. The best compound for AChE inhibition was 8c having 89.24 ± 0.78 % inhibition at 0.5 mM with IC 50 16.43 ± 0.62 μM, while the best against BChE was 8 g with 87.25 ± 0.47 % inhibition and IC 50 31.42 ± 0.34 μM. The whole series of compounds remained potent inhibitors against urease enzyme with better potential as compared to standard thiourea. The potent compounds of the series were 8o and 8i with IC 50 values of 1.32 ± 1.03 μM and 1.38 ± 0.34 μM, respectively. Half of the whole library of compounds ( 8a–q ) possessed outstanding biofilm inhibition potential against the tested bacterial strains and confirmed themselves as better anti-microbial agents. The compounds were also screened for hemolytic activity and results exhibited medium to excellent hemolytic activity. The compound 8b showed the least toxicity among the synthesized compounds, 8a–q . The computational studies of all the synthesized compounds were also carried out to elaborate the binding forces of synthesized compounds with the active sites of enzymes to establish SAR. In silico data supported the in vitro profiles. Further work is suggested for in vivo studies of the most of compounds in search for their anti-cholinesterase and anti-urease potential. Work is in progress on these lines.

Pyrazole-Thiazole Hybrids: Synthesis, Computational Studies and Impact on Digestive Enzymes

Design, synthesis, molecular docking and biological studies of some novel pyrrolidine-triazole-aurone hybrids against digestive enzymes

Synthesis and Molecular Docking of Curcumin‐Derived Pyrazole‐Thiazole Hybrids as Potent α‐Glucosidase Inhibitors

Synthesis, Molecular Docking and in Vitro Screening of Some Newly Synthesized Triazolopyridine, Pyridotriazine and Pyridine–Pyrazole Hybrid Derivatives

Synthesis of thiazolidine-2,4-dione tethered 1,2,3-triazoles as α-amylase inhibitors: In vitro approach coupled with QSAR, molecular docking, molecular dynamics and ADMET studies

Synthesis of Pyrazolo[3,4-b]pyridine Derivatives and Their In-Vitro and In-Silico Antidiabetic Activities

Synthesis, Characterization, Molecular Docking Studies and Biological Evaluation of Some Novel 3,5-disubstituted-1-phenyl-4,5-dihydro-1H-pyrazole Derivatives

Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study

Anti-Diabetic Activities and Molecular Docking Studies of Aryl-Substituted Pyrazolo[3,4-b]pyridine DerivativesSynthesized via Suzuki Cross-Coupling Reaction

Pyrano[2,3-c]pyrazole fused spirooxindole-linked 1,2,3-triazoles as antioxidant agents: Exploring their utility in the development of antidiabetic drugs via inhibition of α-amylase and DPP4 activity

Pyrazoline Spiro-oxindole tethered 1,2,3-triazole hybrids: Design, synthesis, antimicrobial efficacy and molecular modelling studies

Design, Synthesis of 3-(Aryl)-1-(2-p-tolylthiazol-4-yl)prop-2-en-1-ones as Alpha(α)-Amylase Inhibitors

Synthesis, Characterization, In Silico DFT, Molecular Docking, and Dynamics Simulation Studies of Phenylhydrazono Phenoxyquinolones for Their Hypoglycemic Efficacy

Synthesis, α-Glucosidase Inhibition, Anticancer, DFT and Molecular Docking Investigations of Pyrazole Hydrazone Derivatives

Synthesis and biological ( in vitro and in silico ) screening of the 4-aryl-fused pyranopyrazole derivatives as enzyme (α-amylase, α-glucosidase, acetylcholinesterase & proteinase) inhibitors with anti-oxidant and cytotoxic activities

Synthesis, molecular docking study, MD simulation, ADMET, and drug likeness of new thiazolo[3,2-a]pyridine-6,8-dicarbonitrile derivatives as potential anti-diabetic agents

Synthesis, anti-inflammatory, antibacterial, and antioxidant evaluation of novel pyrazole-linked hydrazone derivatives

New piperidinyl heterocyclic azoles acquired through Li(I)-catalyzed reactions: Anti-enzymatic, ADME and computational studies

Synthesis, structural characterizations, in vitro biological evaluation and computational investigations of pyrazole derivatives as potential antidiabetic and antioxidant agents

Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, in vitro and in vivo anti-diabetic evaluation

Design, synthesis, α -amylase and glucose diffusion inhibition, and molecular docking studies of new indenopyrazolones bearing benzothiazole derivatives